Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Nov 5.
Published in final edited form as: Structure. 2019 Sep 12;27(11):1721–1734.e5. doi: 10.1016/j.str.2019.08.012

Integrative protein modeling in RosettaNMR from sparse paramagnetic restraints

Georg Kuenze 1,2,6,*, Richard Bonneau 3,4,5, Julia Koehler Leman 3,4, Jens Meiler 1,2
PMCID: PMC6834914  NIHMSID: NIHMS1538954  PMID: 31522945

Summary

Computational methods to predict protein structure from nuclear magnetic resonance (NMR) restraints that only require assignment of backbone signals, hold great potential to study larger proteins. Ideally, computational methods designed to work with sparse data need to add atomic detail that is missing in the experimental restraints. We introduce a comprehensive framework into the Rosetta suite that uses NMR restraints derived from paramagnetic labeling. Specifically, RosettaNMR incorporates pseudocontact shifts, residual dipolar couplings, and paramagnetic relaxation enhancements. It continues to use backbone chemical shifts and nuclear Overhauser effect distance restraints. We assess RosettaNMR for protein structure prediction by folding 28 monomeric proteins and eight homo-oligomeric proteins. Furthermore, the general applicability of RosettaNMR is demonstrated on two protein-protein and three protein-ligand docking examples. Paramagnetic restraints generated more accurate models for 85% of the benchmark proteins and, when combined with chemical shifts, sampled high-accuracy models (≤2Å) in 50% of the cases.

Graphical Abstract

graphic file with name nihms-1538954-f0001.jpg

eTOC

NMR spectroscopy has limited application when it comes to large proteins. Labeling with paramagnetic metal ions provides additional long-range distance information for NMR. Kuenze et al. have developed a framework for the Rosetta modeling software that allows using paramagnetic restraints and traditional NMR data for protein structure prediction, protein docking and ligand docking.

Introduction

Structural biology increasingly focuses on large and complex protein systems, such as membrane proteins, multi-subunit assemblies or cellular machineries. For such challenging targets, the major technologies X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy struggle to obtain experimental data that unambiguously defines atomic detail. Limitations in resolution, accuracy, and coverage of individual methods can be bridged by data-driven, integrative modeling that considers multiple types of information simultaneously. Programs like Rosetta (Leaver-Fay et al., 2011), HADDOCK (Dominguez et al., 2003), the Integrative Modeling Platform (IMP) (Russel et al., 2012), or BCL::Fold (Weiner et al., 2014) are pioneering applications that integrate information from multiple biophysical and biochemical sources and have led to structures of complex protein systems (Demers et al., 2014; Robinson et al., 2015).

NMR data are one of the most useful sources of structural information for integrative modeling. Advances in solution-state NMR such as protein deuteration (LeMaster, 1990), relaxation-optimized spectroscopy (Pervushin et al., 1997), methyl labeling (Tugarinov and Kay, 2005), and non-uniform sampling (Paramasivam et al., 2012) have improved sensitivity and spectral resolution and pushed the limit of protein NMR to molecular weights of 50-100 kDa. Nonetheless, NMR datasets from large proteins remain sparse, making 3D structure determination challenging. To facilitate structure determination, computational modeling tools are required that can leverage limited NMR data and translate them into accurate structural models.

A powerful strategy to supplement chemical shifts (CSs) and sparse nuclear Overhauser effect (NOE) data is the use of long-range (up to 40 Å) paramagnetic NMR restraints, arising from interactions of nuclear spins with paramagnetic metal ions or nitroxide spin-labels. Advances in chemical synthesis of metal ion-binding tags (Graham et al., 2011) and strategies for their covalent attachment to biomolecules (Loh et al., 2013) have broadened the applicability of paramagnetic NMR (Crick et al., 2015; Rathinavelan et al., 2014).

Three types of paramagnetic NMR data are commonly used for structure determination: paramagnetic relaxation enhancements (PRE), residual dipolar couplings (RDC), and pseudocontact shifts (PCS). PREs can be detected in any paramagnetic system and provide long-range distance restraints. PCSs and RDCs require anisotropic magnetic susceptibility of the paramagnetic ion (e.g. lanthanides), giving rise to a non-vanishing ΔΧ-tensor and leading to partial alignment of the protein in the magnetic field. The ΔΧ-tensor defines a coordinate system in the protein that is centered on the metal ion and relates the observed PCS and RDC to the polar coordinates of a nuclear spin or spin pair. The PCS is a particularly rich structural restraint because it combines both distance and angular information (Koehler and Meiler, 2011).

The Rosetta suite can use different types of NMR data, mainly for structure prediction. The original RosettaNMR method used backbone CSs to find structurally similar peptide fragments in the Protein Databank (PDB), which are assembled de novo guided by limited NOE distance restraints (Bowers et al., 2000). This method was later expanded to leverage RDCs from conventional (non-paramagnetic) alignment media (Rohl and Baker, 2002). In 2003, Meiler et al. showed that RosettaNMR can be used for structure determination of small proteins to atomic detail from unassigned NMR spectra (Meiler and Baker, 2003). Critical for this approach was the iterative filtering of models through comparison of predicted with experimental CSs (Meiler, 2003). This concept has then been extended with CS-Rosetta for the structure determination of larger proteins from backbone-only CSs and RDCs (Raman et al., 2010; Shen et al., 2008). Incorporating sparse side-chain NOEs obtained from deuterated proteins and improving conformational sampling algorithms increased the application limit of CS-Rosetta to proteins up to 40 kDa (Lange et al., 2012). Further advances came from the inclusion of structural templates from homologous proteins (Shen and Bax, 2015). Rosetta was also combined with PCS data (PCS-Rosetta), achieving model qualities comparable to CS-Rosetta (Schmitz et al., 2012). This approach was extended for PCSs from multiple tagging sites and applied to the solution structure of ERp29, which uncovered flaws in a previous NOE-derived NMR structure (Yagi et al., 2013).

These prior results were obtained with customized frameworks in Rosetta that do not interface with each other and are difficult to integrate into various protocols. For example, previous implementations of PCSs in Rosetta were tailored to protein structure prediction but cannot be used for protein-protein or protein-ligand docking. Moreover, while specific combinations of restraints can be used in Rosetta, it is currently impossible to generally exploit the complementary nature of long-range and local restraints by combining PCSs, RDCs, and PREs with CSs and NOEs. However, combining these restraints will presumably improve the accuracy, precision, and completeness of a model, especially where individual restraint types are too sparse or erroneous. Further, other integrative methods are either tailored to a specific application (e.g. HADDOCK for protein-protein docking) or cannot handle the wide array of NMR data (e.g. the IMP does not support paramagnetic data). NMR structure determination packages e.g. Xplor-NIH (Bermejo and Schwieters, 2018) implement paramagnetic restraints but do not provide modeling algorithms for limited datasets. Therefore, generalizing the frameworks in Rosetta for integrated use of various types of NMR data is highly beneficial for modeling larger and more sophisticated biomolecular systems.

Here we reconcile RosettaNMR with CS-Rosetta and PCS-Rosetta to create one integrated framework that combines long-range paramagnetic data with CSs and NOEs and integrates them in many Rosetta workflows. This required substantial refactoring and generalization of prior NMR scoring methods. A new PRE energy method was added to account for conformational flexibility of the spin-label. RosettaNMR is available as one component of the Rosetta software which is released free of charge for academic users (https://www.rosettacommons.org/software). We show that this framework can easily be combined with popular modeling protocols such as RosettaAbinitio (Simons et al., 1997), RosettaDock (Gray et al., 2003), RosettaLigand (Meiler and Baker, 2006), and RosettaSymmetry (Andre et al., 2007) for a various structure determination tasks. Our framework vastly improves the extensibility and accuracy when modeling from sparse NMR restraints, therefore expanding Rosetta’s rich toolbox for incorporating experimental data into an integrative modeling pipeline.

Results

RosettaNMR offers a versatile platform for integrative modeling with paramagnetic NMR restraints

The success of protein structure modeling from limited NMR data can be markedly improved if different types of NMR data are combined in one calculation. To realize an integrative modeling approach, we extend the suite of NMR tools in Rosetta, which we collectively term RosettaNMR, by paramagnetic NMR data in combination with CSs and NOEs in one single framework (Figure 1).

Figure 1: Macromolecular modeling with RosettaNMR and different types of restraints.

Figure 1:

(A) NMR data accessible through RosettaNMR: CSs aid in the selection of short peptide fragments with known backbone conformations. NOE-derived distances restrain the protein’s tertiary structure and interface with binding partners. Long-range paramagnetic NMR effects provide an orthogonal set of restraints on the position and orientation of internuclear vectors. (B) Workflow of integrative NMR-guided protein structure modeling with Rosetta. NMR data can be incorporated at different stages in the protocol to guide conformational sampling or modify the energy landscape.

We focused our implementation on PCSs, RDCs, and PREs since they are most informative in terms of the protein structure representing long-range distance and/or orientational restraints (Figure 1A). Each data type was implemented as a restraint energy penalty reporting the sum of squared errors between experimental and model-predicted data (details in Data S1). During scoring, the PCS score is obtained by computing the ΔΧ-tensor by singular value decomposition coupled with a grid search over the metal ion coordinates to find the best possible fit. The RDC score is computed analogously by determining the molecular alignment tensor, which is related to the ΔΧ-tensor by a constant pre-factor if alignment originates solely from the paramagnetic metal ion but is different for an external anisotropic medium (e.g. bicelles). To generalize score calculation for any para- or diamagnetic data, we decided to fit PCSs and RDCs separately. Moreover, effective tensor values obtained by fitting PCSs and RDCs tend to be not identical, because the ΔΧ-tensor and the alignment tensor average in different ways. The ΔΧ-tensor is affected by any tag motions that relocate the metal ion relative to the protein whereas RDCs are independent of the distance from the metal ion. Considering structural flexibility becomes even more important when interpreting PREs due to the many degrees of freedom (DOFs) of the spin-label; we have adapted the ensemble averaging approach from Iwahara and Clore for computation of the PRE score (Iwahara et al., 2004). The spin-label is modeled as an ensemble of side-chain conformations which are approximated from a pre-computed rotamer library. An effective distance <r−6> is calculated between the protein nuclear spin and all spin-label conformations, whose structural variability is represented by an order parameter S2.

Rosetta allows manipulating the protein through modeling objects accessible from high-level scripting languages such as PyRosetta (Chaudhury et al., 2010) and Rosetta Scripts (Fleishman et al., 2011). This allows users to build new protocols by mixing and matching different modeling strategies (Figure 1B). The main tools fall into two categories: Movers and Filters. Movers change the conformation of a biomolecule and Filters decide whether the conformation should go into the next stage. One can easily devise new strategies of how paramagnetic restraints can be used to guide conformational sampling or model filtering. We exemplify this flexibility in method development by applying PCSs to ligand docking for which we have designed a PCS ligand scoring grid and a rigid-body sampling Mover, and by providing a supporting PyRosetta protocol (Data S2) for assessing collinearity between ΔΧ-tensors calculated from PCSs and RDCs. Furthermore, RosettaNMR allows adding spin-labels to the chemical database in a straightforward manner to accommodate new spin-label designs.

Paramagnetic NMR data enhance sampling of native-like models in de novo structure prediction

We tested RosettaNMR with RosettaAbinitio (Simons et al., 1997) for de novo structure prediction of 28 monomeric proteins (Table S1) using different types and combinations of NMR data: CSs, RDCs, PCSs, and PREs. We included further RDCs from external alignment media as proxies for paramagnetically-induced RDCs (see footnotes of Table 1 and S1) because only a limited number of RDCs measured with lanthanides could be found. However, the computational treatment of RDCs from both sources is identical. Table 1 summarizes the RMSD100 of the best 1% of models ranked by either RMSD or score. Score-vs-RMSD plots of selected targets are displayed in Figure 2, and for all targets in Figure S1 and S2. Noticeably, paramagnetic data greatly improved sampling of near-native models. In 29 of 34 test cases, the best 1% of models ranked by RMSD had a lower RMSD100 to the native structure when paramagnetic data were included (Figure 3A and 3F), and the average RMSD100 improved from 4.5 Å to 3.5 Å (last row in Table 1; see Figure S3A for statistical analysis of RMSD change).

Table 1:

Structure prediction of monomeric proteins with paramagnetic NMR restraints and CSs

no Paramagnetic NMR Restraints Paramagnetic NMR Restraints
no CSs with CSs no CSs with CSs
PDB
ID
BMRB
ID
Topology No.
Residues
No. NMR
Restraints
Top 1%
RMSDa
Top 10
Scoreb
Top 1%
RMSD
Top 10
Score
Top 1%
RMSD
Top 10
Score
Top 1%
RMSD
Top 10
Score
RDC
1Q2Nc 5656 α 58 126 2.5 5.4 2.1 3.7 1.8 2.5 1.8 2.4
2L7Kc 17359 α 76 79 3.7 9.2 2.6 3.5 2.8 3.1 2.2 3.3
5T1N 30158 α/β 85 57 2.7 3.1 2.8 3.1 2.7 2.9 2.8 3.1
2KYWc,f 16988 β 87 132 7.3 9.1 7.4 8.2 6.9 9.7 6.1 9.2
2KCTc 16096 β 94 49 4.0 4.3 2.4 3.9 3.7 4.7 2.1 2.6
2H45c 7127 β 95 50 2.1 2.5 1.3 1.6 1.4 1.5 1.3 1.5
2KLCc 16390 α 101 75 3.2 3.5 2.3 2.9 1.6 1.9 1.9 2.0
2JV3c 4205 α 110 91 2.8 7.3 2.2 4.7 2.0 3.7 1.7 2.4
1RJV 6049 α 110 46 5.6 10.9 5.6 7.8 7.6 8.9 5.7 6.2
2A7Oc 6834 α 112 120 4.7 11.5 3.0 9.2 2.7 4.0 2.4 2.9
2KCKc 16083 α 112 144 2.7 4.0 2.8 3.8 2.5 2.9 2.3 2.4
2KD1c 16102 α/β 118 105 3.1 4.8 2.6 4.7 2.7 3.4 2.5 2.6
1 CMZc,f 4407 α 128 291 4.9 6.7 4.1 6.6 5.3 7.3 4.5 6.2
2L3Wc 17207 α 143 176 5.5 9.9 4.1 8.4 3.6 5.6 2.7 3.2
2K61 15852 α 146 328 3.5 9.7 2.8 9.2 1.9 2.2 2.2 2.4
2KYYc,f 16991 α/β 152 81 7.0 14.3 5.5 10.9 7.3 13.1 4.6 9.6
2KD7c,f 16107 β 159 137 7.4 10.5 8.0 12.2 7.1 9.1 7.8 9.6
2K5Uc,f 15809 α/β 181 322 6.2 8.1 5.0 6.8 3.7 3.5 3.3 3.5
1 RW5c,f 6643 α 199 81 8.0 12.4 5.6 13.3 5.8 12.3 4.4 11.5
Meand 4.6 7.7 3.8 ** 6.6 ** 3.8 ** 5.4 ** 3.2 *** 4.6 ***
≤ 3 Åd 5 1 11 2 10 6 12 9
≤ 5 Åd 12 6 14 9 13 12 16 13
PCS
2AE9 6571 α 76 86 4.3 14.4 1.8 2.1 1.7 2.2 1.6 2.1
1D3Z 6457 α/β 76 331 3.2 3.8 2.7 3.6 1.6 2.5 1.5 2.7
5T1N 30158 α/β 85 102 2.7 3.1 2.8 3.1 2.7 3.0 2.7 3.0
1X0N 11055 α/β 104 227 3.9 6.9 2.7 5.9 3.3 5.5 2.2 2.8
1G7De 4920 α 106 276 1.8 3.1 2.3 4.0 1.6 4.1 2.2 3.6
1 RJVf 6049 α 110 104 5.5 10.9 5.6 7.8 3.9 8.0 4.6 6.0
2K61 15852 α 146 403 3.5 9.7 2.8 9.2 2.1 2.7 2.3 2.6
1IJA 4879 β 148 41 3.2 4.0 2.7 3.5 2.7 3.0 2.5 3.0
1J54f 6184 α/β 186 480 7.3 12.2 5.7 10.1 6.6 6.2 6.6 7.7
Mean 3.9 7.6 3.2 * 5.5 * 2.9 * 4.1 * 2.9 * 3.7 *
≤ 3 Å 2 0 7 1 6 5 7 6
≤ 5 Å 7 4 7 5 8 6 8 7
PCS+RDC
5T1N 30158 α/β 85 102+57 2.7 3.1 2.8 3.1 2.7 3.0 2.7 3.0
1RJV 6049 α 110 104+46 5.5 10.9 5.6 7.8 4.0 4.5 4.6 5.8
2K61 15852 α 146 403+328 3.5 9.7 2.8 9.2 1.6 2.1 1.6 1.9
Mean 3.9 7.9 3.7 6.7 2.7 3.2 2.9 3.6
≤ 3 Å 1 0 2 0 2 2 2 2
≤ 5 Å 2 1 2 1 3 3 3 2
PRE
3GB1 7280 α/β 56 91 1.0 1.4 0.9 1.4 1.0 1.4 0.9 1.4
1CDLf 1634 α 142+19 120 6.3 10.0 5.3 9.4 4.0 9.4 4.1 7.7
1SOS 4202 α/β 153 179 7.7 8.4 4.4 3.5 7.4 8.6 4.4 4.2
Mean 4.0 6.6 2.9 4.8 3.3 6.5 2.6 4.4
≤ 3 Å 1 1 1 1 1 1 1 1
≤ 5 Å 1 1 2 2 2 1 3 2
All
Mean 4.5 7.6 3.6 *** 6.1 *** 3.5 *** 5.0 *** 3.1 *** 4.2 ***
≤ 3 Å 9 2 21 4 19 14 22 18
≤ 5 Å 22 12 25 17 26 22 30 24
a

Top 1% RMSD: average RMSD100 of best 1% of models ranked by RMSD. The RMSD100 was calculated relative to the experimental structure excluding residues in flexible termini (defined in Table S1).

b

Top 10 Score: average RMSD100 of best 10 models ranked by score. For models generated without paramagnetic restraints, the Rosetta all-atom score was used for model ranking. In calculations with paramagnetic restraints the combined NMR score and Rosetta all-atom energy was used.

c

RDCs induced by a mechanical alignment medium

d

Average RMSD100 per restraint set (‘Mean’) and number of cases with RMSD100 ≤ 3 Å and ≤ 5 Å. The RMSD100 change relative to the case without NMR data was evaluated by a Wilcoxon signed-rank test (nRDC = 19, nPCS = 9, nAll = 34, * p < 0.05, ** p < 0.01, *** p < 0.001) for benchmark sets with sufficiently large sample size. See also Figure S3 for statistical analysis of RMSD100 change.

e

The model of protein 1GD7 was compared to the X-ray structure of human ERp29 (PDB 2QC7) because previous studies (Yagi et al., 2013) uncovered flaws in the structure determined by NMR.

f

Used for iterative refinement (Table S3).

Figure 2: De novo structure prediction of monomeric proteins with paramagnetic and CS data.

Figure 2:

Selected benchmark proteins for which prediction utilized either (A) RDCs (phycobilisome rod linker, PDB 2L3W), (B) PCSs (Grb2 SH2 domain, PDB 1X0N), (C) PREs (B1 domain of protein G, PDB 3GB1), or (D) RDCs and PCSs (calmodulin, PDB 2K61). A complete list of the results of all targets is given in Figure S1 and S2. The combined Rosetta and NMR score and the cumulative fraction of models versus the RMSD100 relative to the reference structure is shown. The NMR score was the (A) RDC, (B) PCS, (C) PRE, or (D) combined PCS+RDC restraint score. The lowest-scoring model from the experiment in which CSs and paramagnetic restraints were applied together is depicted as ribbon (rainbow) and compared to the reference structure in gray. The superposition was optimized for residues in ordered regions (defined in Table S1) and flexible termini are omitted for clarity.

Figure 3: Effect of paramagnetic and CS data on sampling and scoring of de novo predicted models.

Figure 3:

Comparison of the average RMSD100 (± S.D.) of the top 1% of models ranked by RMSD between Rosetta models predicted without NMR data (x-axis) and (A) with only paramagnetic restraints (y-axis) or (B) when CS and paramagnetic data were used. Gray areas indicate an RMSD100 improvement. (C) Model enrichment calculated when models were scored with the standard Rosetta all-atom energy function (−) or an energy function which included an additional RDC, PCS, or PRE score term (+), respectively. Box-and-Whisker plot with whiskers drawn between lowest and highest enrichment value within 1.5 IQR of the lower and upper quartile. Comparison was made by two-tailed Wilcoxon signed-rank test (nRDC = 38, nPCS = 18, nAll = 56, *** p < 0.001). (D) and (E) Comparison of the average RMSD100 among the top ten scoring models from structure predictions with paramagnetic data only or in combination with CSs. (F) Summary of cases in which RosettaNMR yielded more accurate models.

Comparing models generated with either paramagnetic data or CSs (Figure S4), we find that the former had a slightly better performance: for 72% of the proteins paramagnetic data led to a lower RMSD100. Model sampling was most enhanced when RDCs, PCSs, and PREs were combined with CSs (Figure 3B), suggesting that these data have an orthogonal beneficial effect on the conformational search. In 29 of 34 cases, the best 1% of models ranked by RMSD had a lower RMSD100 to the native structure when paramagnetic NMR and CS data were used (Figure 3F), and the average RMSD100 decreased from 4.5 Å to 3.1 Å (last row in Table 1; see Figure S3A for statistical analysis of RMSD change).

The gradual improvement in model sampling by including CSs, paramagnetic restraints, or a combination of both can be seen in the score-vs-RMSD and density plots in Figure 2, S1, and S2. The increase in density of near-native models is apparent in the low RMSD100 region. The fraction of proteins for which a high-accuracy model (RMSD100 ≤ 2 Å) could be generated, increased from 9% (no NMR) to 35% (CSs), 35% (paramagnetic data), and 50% (CSs and paramagnetic data). Medium-accuracy models (≤ 3 Å) could be sampled in 62% (no NMR), 68% (CSs), 76% (paramagnetic data), and 76% (CSs and paramagnetic data) of cases.

Paramagnetic NMR data enrich for native-like models in scoring

A similar improvement in model quality was observed when they were ranked by score (Table 1, Figure 3D and 3E). This is more realistic since in a blind prediction models must be identified mostly by their score. Here, we calculated the score as combination of the Rosetta all-atom energy and the RDC, PCS, or PRE score with a weighting factor that was optimized for each NMR dataset and protein as described under Methods. For those cases where PCSs and RDCs were used, both the PCS and RDC score was added to the Rosetta energy with weights proportional to the logarithm of the number of PCS and RDC values.

For 28 of 34 and 30 of 34 targets the ten best-scoring models had a lower average RMSD100 when paramagnetic restraints were used individually or combined with CSs (Figure 3D and 3E). The average RMSD100 of the ten lowest-scoring models over all proteins improved from 7.6 Å (no NMR) to 5.0 Å (paramagnetic data) and 4.2 Å (CSs and paramagnetic data) (last row in Table 1, Figure S3B). The number of proteins for which the RMSD100 of the top ten models was ≤ 3 Å increased from two (no NMR) to 14 (paramagnetic data) and 18 (CSs and paramagnetic data).

To investigate the ability of the RDC, PCS, and PRE score to recognize near-native models we calculated model enrichment (maximum value is 10, see Method Details) displayed in Figure 3C. To this end, models built without paramagnetic data were rescored with RDCs, PCSs, or PREs and the Rosetta energy function. The average enrichment over the benchmark set increased from 2.5 to 3.7 (RDCs: 2.5 → 3.8; PCSs: 2.2 → 4.1; RDCs + PCSs: 1.9 → 4.2). No significant increase in enrichment was seen for the PRE score (2.5 → 2.6), showing that it failed to further improve model selection with Rosetta’s all-atom energy function. Although we only have experimental PREs from three proteins, the observations match those made with simulated PREs for symmetric proteins (see below). We speculate that the lower discriminative power of the PRE score is because PREs are purely distance-dependent whereas PCSs are sensitive to orientation and distance. In addition, PCSs exhibit a more favorable r−3 distance dependence (r−6 for PREs) and are less affected by the presence of minor protein states or encounter complexes (Clore and Iwahara, 2009). Consequently, the PCS score drastically improves model discrimination when included in Rosetta’s energy function.

Paramagnetic NMR data facilitate model selection

Experimental data can be compared to predicted data for model selection and validation. The top RosettaNMR models satisfy their experimental data remarkably well (Figure 4A-4C for proteins 2K61, 5T1N, and 1CDL, Figure 4D and Table S2). A direct measure of the agreement provides the NMR quality factor (Q-factor), which we calculated for the ten best-scoring models of each target. We saw a steady improvement of the Q-factor with the inclusion of CSs and paramagnetic data; a combination of both restraint types yielded Q-factors comparable to experimental structures (Figure 4D). While model cross-validation against data deliberately left out from the calculation is beyond the scope of this study, we note that we observed improved Q-factors also in cases where paramagnetic data were only used for final model evaluation. For the set of models created with CSs the Q-factors improved on average from 0.58 to 0.52 (RDCs), 0.20 to 0.18 (PCSs), and 0.63 to 0.61 (PREs) relative to the unrestrained calculation (Figure 4D). Improved Q-factors in those cases may reflect increased structure accuracy of RosettaNMR models even when alternative restraints were used in building them.

Figure 4: Agreement of experimental with calculated paramagnetic restraints.

Figure 4:

Correlation between experimental PCSs and RDCs for (A) calmodulin (PDB 2K61) and (B) NPr (PDB 5T1N) with PCSs and RDCs back-calculated from the lowest-scoring model. (C) Correlation of experimental and calculated PREs for the lowest-scoring model of MLCK-peptide-bound calmodulin (PDB 1CDL). In each case, the lowest scoring model obtained with CSs and paramagnetic data was used for the analysis. (D) Average Q-factor (± S.D.) of the ten lowest-scoring models for each prediction target versus the type of NMR data: no NMR – without NMR data, CS – with CSs, ParaNMR – with RDCs, PCSs, or PREs, CS+ParaNMR – with CSs and RDCs, PCSs, or PREs, native – experimental structure after minimization in Rosetta. The individual proteins modeled with either RDCs, PCSs, or PREs are represented by using different shades of blue, green, or yellow, respectively, and lines between data points are used for easier visualization. The average Q-factor across all proteins is given on top of each column. A complete list of Q-factor values is given in Table S2 and S4.

We used two measures to assess the quality and estimate success of structure prediction: a) low Q-factors confirm good agreement with the experimental data and b) model convergence indicates that a topology is repeatedly sampled and satisfies the Rosetta and NMR score. We defined convergence as the average RMSD between the best-scoring model and the next nine low-scoring models. We found that paramagnetic restraints and CSs were highly beneficial for model convergence and a steady RMSD improvement was observed when including more NMR data (Figure S5A). In 28 of 34 cases, the model created with CSs and paramagnetic restraints had a convergence ≤ 4 Å (Table S2, Figure S5A). This RMSD cutoff is used in the calculation of other protein structure similarity metrics (e.g. GDT-TS and MaxSub) and below it models usually have the same global topology. The other six proteins (2KYW, 2KYY, 2KD7, 1RW5, 1CDL, 1J54) had limited convergence, identifying their model as unreliable (Figure S6).

Iterative resampling with paramagnetic NMR data further improves model quality

Inspection of these six prediction failures according to our convergence criterion revealed no high-accuracy model (≤ 2 Å) and only a small number of intermediate-accuracy models (≤ 3 Å) after de novo prediction. Insufficient sampling was also noticed for another three proteins (1CMZ, 1RJV, 2K5U) with consequently high RMSD100 for their top-scoring models. To test if enhanced conformational sampling could improve model accuracy, we applied the Rosetta Iterative Hybridize refinement protocol (Ovchinnikov et al., 2017), incorporating paramagnetic restraints.

We ran 30 rounds of refinement and selected the offspring generation of models at each step by their combined Rosetta and NMR score. The RMSD100 steadily improved for eight of nine proteins; the RMSD100 of the ten lowest-scoring models decreased by 3.2 Å on average, improving the number of proteins with RMSD100 ≤ 5 Å for the ten lowest-scoring models from one of nine to six of nine (Table S3, Figure S7). For two of nine proteins at least one high-accuracy model was present in the pool after refinement.

RosettaNMR with paramagnetic NMR data improves structure prediction of symmetric proteins

We further applied RosettaNMR to symmetric proteins, focusing on systems with cyclical (Cn) and dihedral (Dn) symmetry as they are most abundant in nature. We hypothesized that RDCs, PCSs, and PREs provide sufficient information to fold the asymmetric monomer and sample symmetric rigid body DOFs toward low-energy and experimentally valid conformations. We incorporated point symmetry into the RDC, PCS, and PRE scoring methods, allowing the use of experimental data collected on the whole protein assembly through symmetric tagging. Hence, laborious and time-consuming asymmetric tagging of single subunits to break the symmetry for the ease of assignment is not required.

We combined RosettaNMR and the Fold-and-Dock protocol (Das et al., 2009), which simultaneously models the asymmetric monomer and symmetric complex. The protocol was tested with published RDCs and simulated PCSs and PREs for six dimeric proteins, one protein trimer, and one tetramer (Table 2 and Table S1). In addition, we employed a two-step protocol for proteins 1RJJ and 2M89 for which Fold-and-Dock failed to build models < 10 Å to the native structure. Here, models of the monomer were first built with RosettaAbinitio and then used for symmetric docking.

Table 2:

Structure prediction of symmetric proteins with paramagnetic restraints

no NMR
Restraints
RDC PCS PRE
PDB
ID
BMRB
ID
Symmetry No.
Residues
No. NMR
Restraints a
Top 1%
RMSDb
Top 10
Scoreb
Top 1%
RMSD
Top 10
Score
Top 1%
RMSD
Top 10
Score
Top 1%
RMSD
Top 10
Score
2KBY 25958 D2 4×50 154,115,69 5.6 9.2 1.6 2.1 3.1 3.1 4.0 6.6
2KO8 16492 C3 3×53 43,131,125 7.7 12.0 5.3 4.6 3.9 2.4 6.2 10.1
2JWK 15459 C2 2×74 263,233,168 5.9 10.0 2.3 3.6 2.3 2.2 5.4 7.6
2L01 - C2 2×77 97,223,174 5.5 9.3 3.1 2.7 1.6 1.6 5.4 8.8
2LTD 18469 C2 2×80 102,224,188 3.3 7.0 4.7 9.6 7.0 2.6 2.6 2.6
2KOD 16555 C2 2×88 134,232,173 3.2 8.8 1.9 2.2 4.4 9.3 1.9 2.9
1RJJ 6011 C2 2×111 105,536,359 6.6 11.6 6.1 6.0 4.3 2.7 4.7 8.3
2M89 19235 C2 2×134 92,657,437 3.5 17.3 3.4 15.5 3.3 10.9 3.6 9.6
a

Number of restraints in the order: RDCs, PCSs, PREs. RDCs were experimental data, and PCSs and PREs were simulated (Method Details, Table S1).

b

Top 1% RMSD and Top 10 Score metric as defined in Table 1. For models generated without paramagnetic restraints, the Rosetta all-atom score was used for ranking. Models generated with paramagnetic restraints were identified by the combined NMR and Rosetta score.

Table 2 summarizes the average RMSD100 of the best 1% of models by RMSD and of the ten bestscoring models. Score-vs-RMSD plots of selected proteins are displayed in Figure 5 and for all targets in Figure S8. We found a clear improvement in model sampling and scoring with paramagnetic data. The number of cases with a lower RMSD100 among the best 1% of models was seven (RDCs), six (PCSs), and seven (PREs) out of eight (considering the symmetric docking results for 1RJJ and 2M89), and the average RMSD100 over the best 1% of models for all proteins decreased from 5.2 Å (no NMR) to 3.6 Å (RDCs), 3.8 Å (PCSs), and 4.2 Å (PREs). The sampling density of low-RMSD models improved considerably for many targets; the number of cases with at least one high-accuracy model (≤2 Å) improved from one (no NMR) to five (RDC), six (PCS), and two (PRE). As in our analysis for monomeric proteins, paramagnetic NMR data had a beneficial effect on scoring and convergence. The average enrichment increased from 2.3 to 2.7 (RDCs), 3.1 (PCSs), and 2.4 (PREs) (Figure 5E), and the mean convergence improved from 5.4 Å to 4.2 Å (RDCs), 2.9 Å (PCSs), and 5.1 Å (PREs) (Figure S5B). Using a combination of convergence and NMR Q-factor to assess prediction reliability, five (RDCs), six (PCSs), and three (PREs) out of eight cases could be classified as successful (Figure S6B).

Figure 5: De novo structure prediction of symmetric proteins with paramagnetic NMR data.

Figure 5:

(A) tetramerization domain of p73 (PDB 2KBY), (B) periplasmic domain of TolR, (C) C-terminal domain of HIV-1 capsid protein (PDB 2KOD). Complete results of all symmetric proteins are given in Figure S8. The combined Rosetta and NMR score and the cumulative fraction of models versus the RMSD100 is shown. The NMR score was either the RDC (blue), PCS (green), or PRE (yellow) score. We compare structure prediction without NMR data (black curve) and using RDCs (blue), PCSs (green), or PREs (yellow), respectively. The lowest-scoring model of 2KBY with RDCs (A), of 2JWK with PCSs (B), and of 2KOD with PREs (C) is displayed as ribbon for residues in ordered regions (defined in Table S1) and superimposed onto the experimental structure in gray. (D) Average RMSD100 of the ten best-scoring models for structure prediction with and without paramagnetic NMR data. The sampling of proteins 2M89 and 1RJJ for which paramagnetic restraints led to a higher RMSD100 can be improved by dividing the modeling protocol into two steps: folding of the monomer and docking of the symmetric dimer. The RMSD improvement is illustrated by gray arrows. (E) Model enrichment with an energy function including the respective NMR score compared to the standard Rosetta energy function. Box-Whisker plot; two-tailed Wilcoxon signed-rank test (nAll = 30, *** p < 0.001).

PCSs are highly beneficial to identify native interfaces in protein-protein docking

PCSs are particularly attractive for protein-protein docking because they combine distance and angular information and are easy to interpret in terms of the coordinates of a nucleus within the ΔΧ-tensor frame. This strategy was first realized by implementing PCSs into rigid-body docking approaches (Pintacuda et al., 2006; Ubbink et al., 1998), and later into the docking program HADDOCK (Schmitz and Bonvin, 2011). Here, we combined PCSs in RosettaNMR with RosettaDock (Gray et al., 2003) and show that protein-protein interfaces can be accurately identified using PCS data as the only source of experimental information.

Method performance was assessed on two systems with experimental PCSs (Table 3): a) a ternary complex of FKBP12 (FK506-binding protein), rapamycin and the FKBP12-rapamycin-binding (FRB) domain of FRAP (PDB 1FAP) (Kobashigawa et al., 2012) (Figure 6A and 6B) and b) a homodimer of the PB1 domain of p62 (PDB 2KTR) (Saio et al., 2010) (Figure S9). For FKBP12-rapamycin-FRB , we obtained a best-scoring model with an interface RMSD of 0.5 Å to the X-ray structure (Figure 6A). The final ensemble of ten models was highly converged with an average interface RMSD of 0.6 ± 0.2 Å to the native structure and was in excellent agreement with the PCS data (Q = 0.07). In contrast, docking without PCS data failed to converge; the final ensemble had an average RMSD of 13.2 ± 6.6 Å (Figure 6B).

Table 3:

Structure prediction of protein-protein and protein-ligand complexes with PCS data

no PCS PCS
PDB
ID
BMRB ID Stoichiometry No. Residues No. PCS Restraints Top 1% RMSDa Top 10 Scoreb Top 1% RMSD Top 10 Score
 Protein Docking
2KTR 16361 1:1 100+100 1042 5.3 14.1 2.0 1.7
1FAP 11471 1:1 107+95 404 6.6 13.2 3.2 0.6
 Ligand Docking
1JYR 11055 1:1 100+1 227+15c 8.9 14.7 1.6 1.1
1X0N 11055 1:1 100+1 227+55 9.4 9.8 3.3 1.4
3U11 - 1:1 247+1 223+18 12.2 24.0 2.6 6.7
a

Average RMSD of best 1% models ranked by RMSD.

b

Average RMSD of ten best-scoring models. The interface and ligand RMSD as defined in Method Details were used. Models were ranked by their combined Rosetta energy and PCS score.

c

Number of PCSs for protein+ligand.

Figure 6: Protein-protein and protein-ligand docking with PCS data.

Figure 6:

(A) Docking of the FRB domain of FRAP to the FKBP12-rapamycin complex (PDB 1FAP). The combined Rosetta interface and PCS score and the cumulative fraction of models versus the interface RMSD. The lowest-scoring model obtained with PCS-restrained docking is represented as ribbon diagram with FKBP12 in green, FRB in cyan, and rapamycin in magenta sticks, and superimposed onto the X-ray structure in gray. (B) Average interface RMSD of the ten lowest scoring models for the two docking test cases. The inset compares the average interface RMSD (± S.D.) among the top 1% of models ranked by RMSD. (C) Docking of pYTN tripeptide to the SH2 domain of Grb2. The combined Rosetta interface and PCS score and the cumulative fraction of models versus the ligand RMSD. As comparison served the X-ray structure of a phosphorylated three-residue peptide bound to Grb2 SH2 (PDB 1JYR). The lowest scoring solution of the ligand obtained with PCS-restrained docking is represented as sticks and compared with the ligand in the X-ray structure colored gray. (D) Average ligand RMSD of the ten lowest-scoring models for the three ligand docking cases. The inset compares the average interface RMSD (± S.D.) of the best 1% of models ranked by RMSD. Complete docking results are in Figure S9.

For the p62 PB1 homodimer, our calculations converged to a best-scoring model with an interface RMSD of 1.3 Å (Figure S9). The final ensemble of ten models had an average RMSD of 1.7 ± 0.3 Å and was in good agreement with the experimental PCSs (Q = 0.17). In contrast, docking without PCSs failed to converge and the interface RMSD of the best ten models was 14.1 ± 2.4 Å (Figure 6B) (Q = 0.21).

PCSs efficiently guide protein-ligand docking to native-like complexes

PCSs are beneficial for ligand docking because they can be measured for ligands with a broad range of affinities and provide atomic detail information about the ligand binding mode (Guan et al., 2013). Here, we tested the performance of RosettaNMR with RosettaLigand (Meiler and Baker, 2006) to leverage PCSs for modeling protein-ligand interactions. Using PCSs for three protein-ligand systems with different affinities and no prior knowledge about where the ligand binds, our method recovered the native ligand binding mode with an accuracy of up to 1.1 Å ligand RMSD.

We employed a two-step protocol for global protein-ligand docking. A search of the ligand’s six rigid body DOFs in a grid around the protein identifies positions with low PCS score, which are then used as input into RosettaLigand. Subsequent high-resolution docking refines the structure to atomic detail. Furthermore, we implemented a PCS scoring grid (DeLuca et al., 2015) into RosettaLigand, which evaluates the ligand position given the experimental PCSs and a ΔΧ-tensor as input. The tensor components can be calculated from the proteins’ PCSs prior to docking.

We tested this method on three protein-ligand complexes (Table 3): the SH2 domain of Grb2 bound to a low-affinity phosphorylated pYTN tripeptide as well as a high-affinity macrocyclic inhibitor (Saio et al., 2011), and a complex of dengue virus NS2B-NS3 protease (DENpro) with a high-affinity ligand (Chen et al., 2016). PCS-assisted docking of the two SH2 ligands was converged. The models of the pYTN ligand (Figure 6C) and the macrocyclic inhibitor (Figure S9) with the lowest combined Rosetta interface and PCS score had a ligand RMSD of 1.1 Å in both cases, and were in good agreement with the NMR data (Q = 0.14 and Q = 0.23). The average RMSD of the ten best models was 1.1 ± 0.1 Å and 1.4 ± 0.6 Å, respectively (Figure 6D). In contrast, ligand docking without PCSs failed to identify the binding pocket and led to ligand RMSDs of 14.7 ± 6.9 Å and 9.8 ± 4.5 Å, respectively. Similar improvements were found for the third system, DENpro with a high-affinity ligand. Our lowest scoring model had a PCS Q-factor of 0.11 and a RMSD of 2.1 Å to the model by Chen et al. (Figure S9) which bears high similarity to the X-ray structure of a related peptide-DENpro complex (PDB 3U1I) (Noble et al., 2012).

Discussion

The utility of paramagnetic NMR restraints has long been recognized but such restraints are often too sparse to allow structure determination from these data exclusively. Moreover, interpretation of PCS and RDC data usually requires that the molecular alignment tensor or metal ΔΧ-tensor is calculated from an existing structure and simultaneous computations of tensor and structure (Bryson et al., 2008) have remained difficult and are practical for only small proteins. Consequently, PCSs, RDCs, and PREs have mainly been used in addition to NOEs in structure calculations or refinement (Gabel et al., 2008; Gaponenko et al., 2004). However, computational methods can leverage limited experimental data and integrative modeling approaches have proven successful in assisting structure determination of large proteins and protein assemblies from limited NMR data (Loquet et al., 2012).

We present a strategy for protein structure modeling from paramagnetic restraints as part of Rosetta. Our approach revives and extends the RosettaNMR framework and allows modeling from long-range PCS, RDC, and PRE restraints, in combination with CSs and NOEs. RosettaNMR was designed to be integrable with other modeling protocols such as RosettaAbinitio, RosettaDock, RosettaLigand, and RosettaSymmetry in order to tackle various modeling challenges.

Structures predicted by our method reach comparable accuracy as previous CS- (Shen et al., 2008), PCS- (Schmitz et al., 2012), and CS-RDC-Rosetta (Raman et al., 2010) protocols and improved accuracy compared to BCL::Fold (Weiner et al., 2014) (Table S5). Our analysis shows that paramagnetic restraints greatly enrich for near-native models by improving both model sampling and scoring. Paramagnetic restraints led to more accurate models for 85% of the monomeric benchmark proteins. Combining CSs with paramagnetic restraints sampled at least one high-accuracy model (≤ 2 Å) in 50% of the cases, and a medium-accuracy model (≤ 3 Å) for 75% of the proteins which was not achieved in calculations without NMR data. This clearly illustrates that CSs and paramagnetic restraints complement each other in protein structure determination: CSs guide the fragment search through local conformation bias while paramagnetic restraints guide the global assembly into a 3D fold.

Our results for de novo structure prediction are further confirmed by those obtained on symmetric proteins and for modeling protein-protein and protein-ligand complexes. Paramagnetic restraints improve model quality of up to 80% of the symmetric proteins and help to recapitulate native protein and ligand binding poses with an RMSD as low as 1 Å. Moreover, paramagnetic restraints proved beneficial for model selection. Energy differences between native-like and non-native conformations can be small due to a simplified protein representation in Rosetta and inaccuracies in the energy function, making identification of the correct fold difficult or impossible. Supplementing the Rosetta energy function with a score reporting the PCS, RDC, and/or PRE restraint violation significantly improves model enrichment by a factor of ~2.

Predicting the likelihood of success for structure prediction remains difficult, as various aspects (fold complexity, secondary structure content and composition, number and quality of paramagnetic restraints and spin-label sites) play an important, and protein-specific, role. In general, restraints from multiple tagging sites are expected to improve structure prediction by resolving the degeneracy of solutions that equally fulfill the experimental data. For proteins 1D3Z and 1G7D in our benchmark set for which PCS data from multiple spin-label sites were available the largest RMSD improvements were seen after combining data from all tagging sites, and individual tagging sites were found not equally valuable in sampling low-RMSD models.

Additional improvements to structure prediction with sparse paramagnetic NMR data are expected to come from enhanced sampling methods such as iterative hybridization (Ovchinnikov et al., 2017) or RASREC (Lange and Baker, 2012). These techniques can improve modeling for larger and more complex topologies and make more efficient use of NMR data. Further improvements can be expected from incorporation of alternative experimental data, e.g. from SAXS (Rossi et al., 2015) or MS (Aprahamian et al., 2018) or from co-evolution data (Hopf et al., 2014). Evolutionary coupling-NMR, developed by Tang et al. (Tang et al., 2015), incorporates evolutionary contacts during and after NMR data interpretation and NOE assignment. With the expansion of genomic databases and increased accuracy in protein contact prediction algorithms, evolutionary constraints provide increasingly viable orthogonal structural information to assist NMR-guided protein structure prediction.

In conclusion, we present the development and application of a structure biology framework into the Rosetta software which enables protein structure modeling from sparse paramagnetic NMR datasets where other types of data are difficult or time-consuming to acquire. Approaches like these will open the door for structure determination of large and complex biomolecular assemblies and ultimately our understanding of their biological function.

STAR Methods

Lead Contact and Materials Availability

For information how to download and install Rosetta please visit https://www.rosettacommons.org/software/license-and-download and https://www.rosettacommons.org/docs/latest/Home. Instructions for using RosettaNMR with paramagnetic restraints can be found in the protocol capture (Data S3) accompanying this publication. Any further requests for resources and help should be directed to and will be fulfilled by the lead contact, Georg Kuenze (georg.kuenze@gmail.com).

Method Details

Selection of benchmark proteins

For de novo structure prediction, 28 monomeric and eight symmetric proteins with experimental NMR data were selected (Table S1). The monomeric protein benchmark set included 16 proteins with RDC data, six proteins with PCS data, three proteins with PRE data, and three proteins for which both PCS and RDC data were available. Using experimental NMR data enables us to test our framework in a more realistic setting which synthetically generated data cannot provide. Because only a small number of proteins with paramagnetically-induced RDC data are reported in the literature to the best of our knowledge, we included additional proteins with RDC data induced by conventional alignment media; their computational treatment is identical. In addition, CSs were available for all proteins and taken from their BMRB entries. These included CSs of backbone atoms 1HN, 1Hα, 13Cα, 13C’, 13Cβ, 15NH for almost all proteins. 13C’ shifts were not available for proteins 2H45, 2A7O, 1CMZ, 5T1N, 1X0N, and 1RJV, 13Cβ shifts were missing for 1G7D and 1CDL, and 1Hα shifts were absent for 2K61 and 1J54.

To compare with previous structure prediction studies from sparse NMR data, our benchmark set included 14 targets from the BCL::Fold benchmark (Weiner et al., 2014), seven targets from previous CS-Rosetta benchmarks (Raman et al., 2010; Shen et al., 2008), and 4 targets from the PCS-Rosetta benchmark (Schmitz et al., 2012). Furthermore, proteins were selected to have a diverse set of alpha, beta and alpha/beta topologies, and ranged from 56 to 199 residues.

The symmetric protein benchmark set comprised six targets with C2 symmetry (PDB 2JWK (Parsons et al., 2008), PDB 2L01, PDB 2LTD, PDB 2KOD (Byeon et al., 2009), PDB 1RJJ (Cornilescu et al., 2004), PDB 2M89 (Rossi et al., 2015)), one target with C3 symmetry (PDB 2KO8 (Sachleben et al., 2010)), and one target with D2 symmetry (PDB 2KBY (Coutandin et al., 2009)). All symmetric proteins had experimental RDC data available, and PCSs and PREs were simulated. Three targets were taken from an earlier CS-RDC-Rosetta study on symmetric proteins (Sgourakis et al., 2011).

The following structures with PDB IDs were used as reference structures: 1Q2N (Zheng et al., 2004), 2L7K, 2KYW, 2KCT, 2H45 (Vakonakis et al., 2007), 2KLC, 2JV3 (Slupsky et al., 1998), 2A7O (Li et al., 2006), 2KCK, 2KD1, 1CMZ (de Alba et al., 1999), 2L3W, 2KYY, 2KD7, 2K5U (Liu et al., 2009), 1RW5 (Teilum et al., 2005), 2AE9 (Mueller et al., 2005), 1D3Z (Cornilescu et al., 1998), 1X0N (Ogura et al., 2008), 1G7D (Liepinsh et al., 2001), 2QC7 (Barak et al., 2009), 1IJA (Ilangovan et al., 2001), 1J54 (Hamdan et al., 2002), 5T1N (Strickland et al., 2016), 1RJV (Baig et al., 2004), 2K61 (Bertini et al., 2009), 3GB1 (Kuszewski et al., 1999), 1CDL (Meador et al., 1992), 1SOS (Parge et al., 1992), 2KBY (Coutandin et al., 2009), 2KO8 (Sachleben et al., 2010), 2JWK (Parsons et al., 2008), 2L01, 2LTD, 2KOD (Byeon et al., 2009), 1RJJ (Cornilescu et al., 2004), 2M89 (Rossi et al., 2015).

Simulation of PCS data for symmetric proteins

For each symmetric protein, two spin-label sites were chosen focusing on solvent-exposed residues in the middle of secondary structure elements because it was assumed that those sites infer a reduced flexibility on the spin-label and have limited effect on protein stability which would render them possible candidates for experimental lanthanide ion tagging. The lanthanide ion was placed 6 Å away from the Cβ atom of the selected residue in the direction of the Cα-Cβ bond vector, consistent with the approximate side chain length of small lanthanide binding tags. 1HN PCS data were generated for two lanthanides (Tb3+, Tm3+) using ΔΧ-tensors with magnitudes commonly found in the literature (Bertini et al., 2001) and random values for Euler angles α, β, and γ. A uniform random error in the range of ± 0.1 ppm was added and all residues with a magnitude of the PCS value greater than 2.0 ppm were excluded to account for the fact that large PCS effects of residues close to the metal ion are usually not detected in an experimental setting because the PRE effect broadens their NMR signal beyond detection.

Simulation of PRE data for symmetric proteins

Two spin-label sites per symmetric protein were selected using the same criteria as for simulating PCSs, i.e. a solvent-exposed residue located in a continuous stretch of secondary structure. In addition, protein 2M89 offers a solvent-exposed cysteine residue which was also selected as a spin-label site. 1HN-Γ2 PREs were simulated by placing all distinct, non-clashing side-chain conformations of the MTSL residue at the designated spin-label site and assigning them a weight proportional to their Boltzmann-weighted rotamer energy. The PRE was calculated from this spin-label ensemble using a modified version of the PRE equations for dipole-dipole relaxation (Iwahara et al., 2004) as well as theoretical values of s, g, and Te appropriate for a nitroxide radical (Koehler and Meiler, 2011), and values of 14.1 T and 298 K for B0 and T. An internal correlation time of 10−3 ns of the spin-label was assumed and the rotational correlation time of the protein was estimated from its molecular mass using the Stokes-Einstein relationship. A uniform random error in the range between 0-20 Hz was added and all residues with a PRE rate > 200Hz (this amounts to an approximate 1HN-radical distance of < 10-12 Å) were excluded, to account for the fact that NMR signals of residues close to the spin-label are usually undetectable because their NMR line is broadened beyond detection.

Calculation of the paramagnetic NMR score

PCSs, RDCs, and PREs are evaluated by a Rosetta scoring method in low- and high-resolution mode and computed on the whole protein structure. The score represents the sum of squared errors between the experimental and predicted PCS, RDC, and PRE values. Computation of each of the three score terms is described in detail in supporting file Data S1. Detailed description of the format of PCS, RDC, and PRE input files, the choice of critical parameters, and complete command lines are provided with the protocol capture in file Data S3.

Analogous to previous Rosetta protocols for NMR structure determination (Raman et al., 2010; Schmitz et al., 2012; Shen et al., 2008), we decided to add each paramagnetic NMR score to the Rosetta energy function using a different weight (WParaNMR), which was adjusted such that the ranges of the NMR and Rosetta score were approximately equal. The weight was determined by first generating 1000 models without NMR data and then rescoring them with the respective paramagnetic NMR restraints. The weight WParaNMR was calculated as

wParaNMR=ERosettahigh−ERosettalowEParaNMRhigh−EParaNMRlow (1)

where ERosettahigh and ERosettalow are the average of highest and lowest 10% of the values of the Rosetta score, and EParaNMRhigh and EParaNMRlow are the average of the highest and lowest 10% of the values of the respective paramagnetic NMR score, respectively. For de novo structure prediction, ERosetta represented the Rosetta low-resolution score which is obtained using the score3 weight set. For scoring all-atom models, ERosetta was calculated with the Rosetta all-atom ref2015 energy function. In case EParaNMR comprised more than one type of paramagnetic NMR data, WParaNMR was split between those, and we chose a ratio proportional to the logarithm of the number of restraints in each data set.

RosettaNMR de novo structure prediction with paramagnetic and chemical shift NMR data

Structure prediction was accomplished using Rosetta’s fragment assembly protocol (Simons et al., 1997) followed by all-atom refinement via FastRelax (Tyka et al., 2011). Paramagnetic NMR data were used as follows: CSs for fragment selection, PCS, RDC, and PRE data for low-resolution fragment assembly, high-resolution refinement, model scoring, and final model selection.

The fragment search was carried out with the Rosetta3 fragment picker application (Vernon et al., 2013) and two libraries were generated for each protein. For the first library, only sequence-based secondary structure information was used, which was the consensus of two prediction methods, PSIPRED (Jones, 1999) and Jufo9D (Koehler et al., 2009). The second library was created using backbone CSs and secondary structure assignment predicted with the program TALOS+ (Shen et al., 2009). In all cases, homologous proteins present in the database were excluded according to a sequence similarity criterion (PSI-BLAST E-value < 0.5).

To guide fragment assembly with RDCs, PCSs, or PREs, the score function at each of the four assembly stages was supplemented with the score term for the respective paramagnetic NMR restraint, using a weighting factor WParaNMR optimized against Rosetta’s low-resolution score as described above. Following high-resolution refinement, models were rescored with the Rosetta all-atom energy function combined with their respective paramagnetic NMR score term.

For each target in our monomeric protein benchmark set, 10,000 all-atom models were generated, and computations were run on our local ACCRE cluster. Computation times ranged from 0.25 – 0.5 hrs/model for RDCs, 0.5 – 1.0 hrs/model for PREs and 0.5 – 2.0 hrs/model for PCSs.

The performance of RosettaNMR structure prediction was evaluated by calculating model RMSD100 to the native structure, model convergence and NMR Q-factor. The effect of the PCS, RDC, and PRE score on model scoring was assessed using the enrichment metric.

Performance metrics for protein structure prediction

For assessing the performance of paramagnetic NMR data for protein structure modeling with Rosetta, several evaluation metrics were used. The prediction accuracy was quantified by using the Cα-RMSD100 which represents a normalized RMSD relative to a protein size of 100 amino acids (Carugo and Pongor, 2001) and was calculated over all residues in ordered regions of the protein as defined in Table S1 relative to the experimental structure. For proteins determined by NMR the first model of the ensemble was used as reference structure. The RMSD100 measure is useful when comparing proteins of varying size such as those used in this benchmark. For symmetric proteins, the Cα-RMSD100 was evaluated on the oligomeric model, and for proteins with more than two chains was calculated by testing all possible chain orderings because the order of chains in the Rosetta output models is arbitrary.

The effect of the PCS, RDC and PRE score term on scoring of protein structure models was assessed by the enrichment metric, defined as (TP/(TP + FP) × (P + N)/P). Therefore, models were sorted according to either their Rosetta score or their combined Rosetta and NMR score. Models that fell within the top 10% by score were counted as “positive” (P) and the remaining models were counted as “negative” (N). The positives were then sorted by RMSD100 and those models that fell within the top 10% by RMSD100 were labeled “true positives” (TP); all other models were considered “false positives” (FP). Since the (P + N)/P ratio is set to 10, the maximum possible enrichment is also limited to a value of 10.

For a blind structure prediction, it is important to discern whether the final model is reliable or not. As a discrimination measure of a structure prediction we used a combination of two criteria which were evaluated on the 10 lowest-scoring models: backbone convergence and NMR Q-factor. A structure calculation was considered converged if the Cα-RMSD between the lowest-scoring model and the next nine low-scoring models computed for all DSSP-assigned secondary structure (Kabsch and Sander, 1983) regions was less than 4 Å on average. A similar RMSD cutoff is employed in the calculation of other protein structure similarity metrics (e.g. GDT-TS and MaxSub). The agreement with the experimental NMR data was assessed by computing the NMR Q-factor according to Cornilescu et al. (Cornilescu et al., 1998), Q=∑(ccalc−cexp)2∕∑(cexp)2 where ccalc and cexp correspond to the calculated and experimental value of the PCS (c=δiPCS), RDC (c = Dij), or PRE (c = Γi), respectively. A Q-factor below 0.25 in case of PCSs, and below 0.5 for RDCs and PREs indicates a good structural model consistent with the experimental data.

RosettaNMR symmetric protein modeling with paramagnetic NMR data

Structure prediction of symmetric proteins was accomplished using the Fold-and-Dock protocol (Das et al., 2009) which carries out simultaneous folding and docking of multi-chain homo-oligomers. It allows predicting structures of intertwined symmetric assemblies for which the monomer is not stable in isolation and hence not amenable to a two-step approach in which the monomer structure is first predicted and then docked together. We adjusted the Fold-and-Dock protocol to include RDC, PCS, and PRE data for fragment assembly, rigid body sampling, and final model scoring and selection.

In a symmetric complex, the PCSs and PREs are calculated as the sum over equivalent spins in symmetric subunits. For evaluating RDCs, we expect that one axis of the alignment tensor is collinear with the symmetry axis of the system. Thus, a copy of the RDC values is assigned to each subunit, and simultaneous search of all rigid body DOFs during the structure calculation finds the orientation of the alignment tensor that best aligns with the symmetry axis.

We used published RDCs (Table 2 and Table S1) and simulated PCSs and PREs. The type of symmetry, cyclical or dihedral, was assumed to be known. For unknown symmetry groups, all eligible point groups can be tested under the assumption that models with correct symmetry will score better with higher convergence.

A total of 5,000 models were generated for each symmetric protein, which took only slightly longer than structure prediction for monomeric proteins of similar sizes. The respective paramagnetic NMR score was computed for all models, multiplied by the weighting factor WParaNMR and added to the Rosetta all-atom score for final model selection.

An additional two-step modeling protocol (Sgourakis et al., 2011) was conducted for proteins 1RJJ and 2M89, for which Rosetta failed to produce models with RMSD100 < 10 Å to the native structure. The structure of the monomer was first modeled without NMR data using de novo prediction and subsequently docked together using RDC, PCS or PRE data. An ensemble of the 50 lowest-scoring monomer models was used as starting conformations for symmetric docking. This step yielded a total of 50,000 models which were ranked by the Rosetta all-atom interface score together with their paramagnetic NMR score to select final models.

RosettaNMR protein-protein docking guided by PCS data

The RosettaDock algorithm runs in two sampling stages: a low-resolution rigid-body docking stage, in which the orientation of the binding partners is randomly perturbed to find an initial binding interface, and a subsequent all-atom refinement stage to optimize the rigid body position and side chain conformations at the interface (Gray et al., 2003). We have adapted RosettaDock to use PCS data both for rigid body sampling and high-resolution refinement. The PCS score for every tagging site is minimized over all intra- and intermolecular PCSs to yield the ΔΧ-tensor with the best fit to a given docking pose. Thus, incorrect binding poses with a large number of PCS violations are highly penalized. Moreover, rigid body DOFs and backbone torsion angles are further optimized during high-resolution refinement under the restraint of the PCS target function.

PCS-guided Rosetta docking was tested for two protein complexes with experimental PCS data: a homodimer of the PB1 domain of p62 (PDB ID 2KTR) and a ternary complex of FKBP12 (FK506-binding protein), rapamycin and the FKBP12-rapamycin-binding (FRB) domain of FRAP (PDB ID 1FAP). Prior to docking, both binding partners were refined individually with FastRelax (Tyka et al., 2011) to idealize the structures and pre-generate an ensemble of backbones to account for conformational changes between the unbound and bound state.

RosettaDock calculations were performed as global docking with random initial orientations of the two binding partners at the beginning of each simulation. The magnitude of translational and rotational rigid body Monte Carlo moves was set to 0.3 Å and 5°, respectively. For the ternary FKBP12-rapamycin-FRB complex, the rapamycin ligand was kept fixed with respect to FKBP12 and the FRB domain was docked to the FKBP12-rapamycin complex. Simultaneous optimization of protein side-chain rotamers and rapamycin conformers (with internal ligand DOFs) during high-resolution docking and final gradient minimization allowed for an equal adjustment of all protein-protein and protein-ligand interfaces.

A total of 100,000 models were generated for each target with and without PCS data and final models were selected by their combined Rosetta interface and PCS score. Model accuracy was evaluated by the RMSD of all backbone heavy atoms in the interface after superposition. The interface was defined as all residues within 8 A of any other residue on the other protein binding partner.

RosettaNMR protein-ligand docking guided by PCS data

Protein-ligand docking in RosettaLigand (Meiler and Baker, 2006) is carried out in two stages: In an initial low-resolution phase the ligand is placed in a favorable non-clashing position in the binding pocket and during a subsequent high-resolution phase the protein-ligand complex is refined by Monte Carlo simulated annealing minimization of ligand conformers and protein side-chain rotamers. To explore the full potential of the PCSs without prior knowledge of the ligand binding site, we made the following adaptations to the RosettaLigand protocol: First, to identify ligand positions with low PCS score, an additional pre-transform step runs a grid search of the ligand’s rigid body DOFs in a shell around the protein (with adjustable resolution; 5 Å and 20° in this study). These ligand positions (10 0 in this study) are then used as starting points for RosettaLigand’s low-resolution search. For comparison, docking without PCS data was initiated from positions uniformly distributed in a shell around the protein surface with a width corresponding to half the ligand neighbor radius and a spacing of 5 Å. Second, the Cartesian grid-based energy function that is used for ligand scoring during the low-resolution stage (DeLuca et al., 2015) was extended by a new PCS scoring grid, which represents the 3D field of the expected ligand PCS given a ΔΧ-tensor as input. Thus, the PCS ligand grid score examines the agreement of the ligand position with the localization space defined by the PCS. The ΔΧ-tensor components can be determined beforehand by fitting the PCS dataset available for the protein. To ensure that the PCS scoring grid was sufficiently large and that all ligand atoms remained within the grid when the ligand was translated to its maximum allowed distance of 5 Å, the dimensions of the grid were set to 30 Å × 30 Å × 30 Å with a spacing of 0.25 Å. Initially, the grid is centered at the position of the ligand neighbor atom at the beginning of the algorithm but is recomputed if the ligand moves outside of the grid.

After low-resolution docking the algorithm proceeds with its high-resolution phase using the Rosetta all-atom energy function including the PCS score. Six cycles of alternating protein side-chain and ligand conformer packing and small perturbations to the ligand (up to 0.1 Å and 20°) are performed, followed by a final gradient minimization of the interface. A total of 100,000 models were generated with and without PCS data, and final models were selected by their combined interface and PCS score. Model accuracy was assessed by the RMSD of all ligand heavy atoms without superposition.

We applied PCS-guided RosettaLigand to three systems for which experimental PCS data had been published: two complexes of the Src homology 2 (SH2) domain of the growth factor receptor-bound protein 2 (Grb2) with a low-affinity pYTN tripeptide and a high-affinity inhibitor (4-[(10S,14S, 18S)-18-(2-amino-2-oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]icos-11-en-10-yl]benzylphosphonic acid) (Saio et al., 2011), and a complex between the dengue virus NS2B-NS3 protease (DENpro) with a high affinity ligand (Chen et al., 2016).

Quantification and Statistical Analysis

Calculation of the mean (± S.D.) Cα-atom RMSD of the best 1% models by RMSD and the ten top-scoring models listed in Table 1, 2, and 3 and displayed in Figure 3, 5, and 6 was carried out with Numpy as available with Anaconda. Statistical significance of the difference in model enrichment and RMSD for calculations with and without paramagnetic restraints was evaluated by a two-tailed Wilcoxon signed-rank test and carried out with Scipy as available with Anaconda. Significance values (* p < 0.05, ** p < 0.01, *** p < 0.001) are listed in Table 1 and displayed in Figure 3, 5 and S3, where n refers to the number of benchmark proteins per type of NMR restraint (i.e. RDC, PCS or PRE).

Data and Code Availability

The Rosetta software is freely available for academic users at https://www.rosettacommons.org/. A license must be obtained from the University of Washington through the Express Licensing Program (https://www.rosettacommons.org/software/license-and-download). The paramagnetic RosettaNMR framework is part of Rosetta as of version v2019.02-dev60579 and later (for information see also: https://www.rosettacommons.org/docs/latest/application_documentation/RosettaNMR-with-Paramagnetic-Restraints). A protocol capture containing detailed instructions how to run RosettaNMR calculations with paramagnetic NMR data as well as accompanying input files and command lines is available with file Date S3. An example script for how to use RosettaNMR through PyRosetta is provided with file Data S2.

Supplementary Material

1

Data S1: Calculation details of the PCS, RDC, and PRE score; related to STAR Methods.

2

Data S2: Protocol development with RosettaNMR through the PyRosetta interface; related to STAR Methods.

3
4

Data S3: Protocol capture for RosettaNMR; related to STAR Methods.

Key Resource Table

REAGENT or
RESOURCE
SOURCE IDENTIFIER
Software and Algorithms
Rosetta3 (Leaver-Fay et al., 2011) https://www.rosettacommons.org/software
PyRosetta-4 (Chaudhury et al., 2010) http://www.pyrosetta.org/dow
TALOS+ (Shen et al., 2009) https://spin.niddk.nih.gov/NMRPipe/talos/
PSIPRED (Jones, 1999) http://bioinf.cs.ucl.ac.uk/psipred/
Jufo9D (Koehler et al., 2009) http://www.meilerlab.org/index.php/
PyMOL The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC https://pymol.org/
Anaconda Anaconda Software Distribution.
Computer software. Vers. 2-2.4.0.
Anaconda, Inc., Nov. 2017. Web
https://www.anaconda.com

Highlights.

  • A new computational framework for paramagnetic NMR data is introduced in Rosetta

  • Using PCS, RDC and PRE data with CSs and NOEs allows integrative structure modeling

  • RosettaNMR leverages de novo prediction and modeling of protein and ligand complexes

  • Paramagnetic data generate high-accuracy (≤2Å) models for 50% of benchmark proteins

Acknowledgements

This work was supported by NIH grant R01 GM080403. GK was supported by fellowships from the German Research Foundation (KU 3510/1-1) and the American Heart Association (18POST34080422). JKL and RB were funded by the Flatiron Institute as part of the Simons Foundation. This work was conducted using the resources of the Advanced Computing Center for Research and Education (ACCRE) at Vanderbilt University.

Footnotes

Declaration of Interests

The authors declare no competing interests.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Andre I, Bradley P, Wang C, and Baker D (2007). Prediction of the structure of symmetrical protein assemblies. Proc Natl Acad Sci U S A 104, 17656–17661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aprahamian ML, Chea EE, Jones LM, and Lindert S (2018). Rosetta Protein Structure Prediction from Hydroxyl Radical Protein Footprinting Mass Spectrometry Data. Anal Chem 90, 7721–7729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baig I, Bertini I, Del Bianco C, Gupta YK, Lee YM, Luchinat C, and Quattrone A (2004). Paramagnetism-based refinement strategy for the solution structure of human alpha-parvalbumin. Biochemistry 43, 5562–5573. [DOI] [PubMed] [Google Scholar]
  4. Barak NN, Neumann P, Sevvana M, Schutkowski M, Naumann K, Malesevic M, Reichardt H, Fischer G, Stubbs MT, and Ferrari DM (2009). Crystal structure and functional analysis of the protein disulfide isomerase-related protein ERp29. J Mol Biol 385, 1630–1642. [DOI] [PubMed] [Google Scholar]
  5. Bermejo GA, and Schwieters CD (2018). Protein Structure Elucidation from NMR Data with the Program Xplor-NIH. Methods Mol Biol 1688, 311–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bertini I, Donaire A, Jimenez B, Luchinat C, Parigi G, Piccioli M, and Poggi L (2001). Paramagnetism-based versus classical constraints: an analysis of the solution structure of Ca Ln calbindin D9k. J Biomol NMR 21, 85–98. [DOI] [PubMed] [Google Scholar]
  7. Bertini I, Kursula P, Luchinat C, Parigi G, Vahokoski J, Wilmanns M, and Yuan J (2009). Accurate solution structures of proteins from X-ray data and a minimal set of NMR data: calmodulin-peptide complexes as examples. J Am Chem Soc 131, 5134–5144. [DOI] [PubMed] [Google Scholar]
  8. Bowers PM, Strauss CEM, and Baker D (2000). Denovo protein structure determination using sparse NMR data. J. Biomol. NMR 18, 311–318. [DOI] [PubMed] [Google Scholar]
  9. Bryson M, Tian F, Prestegard JH, and Valafar H (2008). REDCRAFT: a tool for simultaneous characterization of protein backbone structure and motion from RDC data. J Magn Reson 191, 322–334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Byeon IJ, Meng X, Jung J, Zhao G, Yang R, Ahn J, Shi J, Concel J, Aiken C, Zhang P, et al. (2009). Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139, 780–790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carugo O, and Pongor S (2001). A normalized root-mean-square distance for comparing protein three-dimensional structures. Protein Sci 10, 1470–1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chaudhury S, Lyskov S, and Gray JJ (2010). PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta. Bioinformatics 26, 689–691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chen WN, Nitsche C, Pilla KB, Graham B, Huber T, Klein CD, and Otting G (2016). Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets. J Am Chem Soc 138, 4539–4546. [DOI] [PubMed] [Google Scholar]
  14. Clore GM, and Iwahara J (2009). Theory, Practice, and Applications of Paramagnetic Relaxation Enhancement for the Characterization of Transient Low-Population States of Biological Macromolecules and Their Complexes. Chemical Reviews 109, 4108–4139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cornilescu G, Cornilescu CC, Zhao Q, Frederick RO, Peterson FC, Thao S, and Markley JL (2004). Solution structure of a homodimeric hypothetical protein, At5g22580, a structural genomics target from Arabidopsis thaliana. J Biomol NMR 29, 387–390. [DOI] [PubMed] [Google Scholar]
  16. Cornilescu G, Marquardt JL, Ottiger M, and Bax A (1998). Validation of Protein Strcuture from Anisotropic Carbonyl Chemical Shifts in a Dilute Liquid Crystalline Phase. J. Am. Chem. Soc 120, 6836–6837. [Google Scholar]
  17. Coutandin D, Lohr F, Niesen FH, Ikeya T, Weber TA, Schafer B, Zielonka EM, Bullock AN, Yang A, Guntert P, et al. (2009). Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ 16, 1582–1589. [DOI] [PubMed] [Google Scholar]
  18. Crick DJ, Wang JX, Graham B, Swarbrick JD, Mott HR, and Nietlispach D (2015). Integral membrane protein structure determination using pseudocontact shifts. J Biomol NMR 61, 197–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Das R, Andre I, Shen Y, Wu Y, Lemak A, Bansal S, Arrowsmith CH, Szyperski T, and Baker D (2009). Simultaneous prediction of protein folding and docking at high resolution. Proc Natl Acad Sci U S A 106, 18978–18983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. de Alba E, de Vries L, Farquhar MG, and Tjandra N (1999). Solution Structure of Human GAIP (Galpha Interacting Protein): A Regulator of G Protein Signaling. J. Mol. Biol 291, 927–939. [DOI] [PubMed] [Google Scholar]
  21. DeLuca S, Khar K, and Meiler J (2015). Fully Flexible Docking of Medium Sized Ligand Libraries with RosettaLigand. PLoS One 10, e0132508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Demers JP, Habenstein B, Loquet A, Kumar Vasa S, Giller K, Becker S, Baker D, Lange A, and Sgourakis NG (2014). High-resolution structure of the Shigella type-III secretion needle by solid-state NMR and cryo-electron microscopy. Nat Commun 5, 4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Dominguez C, Boelens R, and Bonvin AM (2003). HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125, 1731–1737. [DOI] [PubMed] [Google Scholar]
  24. Fleishman SJ, Leaver-Fay A, Corn JE, Strauch EM, Khare SD, Koga N, Ashworth J, Murphy P, Richter F, Lemmon G, et al. (2011). RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite. PLoS One 6, e20161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Gabel F, Simon B, Nilges M, Petoukhov M, Svergun D, and Sattler M (2008). A structure refinement protocol combining NMR residual dipolar couplings and small angle scattering restraints. J Biomol NMR 41, 199–208. [DOI] [PubMed] [Google Scholar]
  26. Gaponenko V, Sarma SP, Altieri AS, Horita DA, Li J, and Byrd RA (2004). Improving the accuracy of NMR structures of large proteins using pseudocontact shifts as long-range restraints. J Biomol NMR 28, 205–212. [DOI] [PubMed] [Google Scholar]
  27. Graham B, Loh CT, Swarbrick JD, Ung P, Shin J, Yagi H, Jia X, Chhabra S, Barlow N, Pintacuda G, et al. (2011). DOTA-amide lanthanide tag for reliable generation of pseudocontact shifts in protein NMR spectra. Bioconjug Chem 22, 2118–2125. [DOI] [PubMed] [Google Scholar]
  28. Gray JJ, Moughon S, Wang C, Schueler-Furman O, Kuhlman B, Rohl CA, and Baker D (2003). Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J Mol Biol 331, 281–299. [DOI] [PubMed] [Google Scholar]
  29. Guan JY, Keizers PH, Liu WM, Lohr F, Skinner SP, Heeneman EA, Schwalbe H, Ubbink M, and Siegal G (2013). Small-molecule binding sites on proteins established by paramagnetic NMR spectroscopy. J Am Chem Soc 135, 5859–5868. [DOI] [PubMed] [Google Scholar]
  30. Hamdan S, Carr PD, Brown SE, Ollis DL, and Dixon NE (2002). Structural basis for proofreading during replication of the Escherichia coli chromosome. Structure 10, 535–546. [DOI] [PubMed] [Google Scholar]
  31. Hopf TA, Scharfe CP, Rodrigues JP, Green AG, Kohlbacher O, Sander C, Bonvin AM, and Marks DS (2014). Sequence co-evolution gives 3D contacts and structures of protein complexes. Elife 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ilangovan U, Ton-That H, Iwahara J, Schneewind O, and Clubb RT (2001). Structure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureus. Proc Natl Acad Sci U S A 98, 6056–6061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Iwahara J, Schwieters CD, and Clore GM (2004). Ensemble approach for NMR structure refinement against 1H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule. J Am Chem Soc 126, 5879–5896. [DOI] [PubMed] [Google Scholar]
  34. Jones DT (1999). Protein Secondary Structure Prediction Based on Position-specific Scoring Matrices. J. Mol. Biol 292, 195–202. [DOI] [PubMed] [Google Scholar]
  35. Kabsch W, and Sander C (1983). Dictionary of Protein Secondary Structure: Pattern Recognition of Hydrogen-Bonded and Geometrical Features. Biopolymers 22, 2577–2637. [DOI] [PubMed] [Google Scholar]
  36. Kobashigawa Y, Saio T, Ushio M, Sekiguchi M, Yokochi M, Ogura K, and Inagaki F (2012). Convenient method for resolving degeneracies due to symmetry of the magnetic susceptibility tensor and its application to pseudo contact shift-based protein-protein complex structure determination. J Biomol NMR 53, 53–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Koehler J, and Meiler J (2011). Expanding the utility of NMR restraints with paramagnetic compounds: background and practical aspects. Prog Nucl Magn Reson Spectrosc 59, 360–389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Koehler J, Woetzel N, Staritzbichler R, Sanders CR, and Meiler J (2009). A unified hydrophobicity scale for multispan membrane proteins. Proteins 76, 13–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kuszewski J, Gronenborn AM, and Clore GM (1999). Improving the Packing and Accuracy of NMR Structures with a Pseudopotential for the Radius of Gyration. Journal of the American Chemical Society 121, 2337–2338. [Google Scholar]
  40. Lange OF, and Baker D (2012). Resolution-adapted recombination of structural features significantly improves sampling in restraint-guided structure calculation. Proteins: Structure, Function, and Bioinformatics 80, 884–895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lange OF, Rossi P, Sgourakis NG, Song Y, Lee HW, Aramini JM, Ertekin A, Xiao R, Acton TB, Montelione GT, et al. (2012). Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with sparse NMR data from deuterated samples. Proc Natl Acad Sci U S A 109, 10873–10878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufman K, Renfrew PD, Smith CA, Sheffler W, et al. (2011). ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol 487, 545–574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. LeMaster DM (1990). Deuterium labelling in NMR structural analysis of larger proteins. Q Rev Biophys 23, 133–174. [DOI] [PubMed] [Google Scholar]
  44. Li M, Phatnani HP, Greenleaf AL, and Zhou P (2006). NMR assignment of the SRI domain of human Set2/HYPB. J Biomol NMR 36 Suppl 1, 5. [DOI] [PubMed] [Google Scholar]
  45. Liepinsh E, Baryshev M, Sharipo A, Ingelman-Sundberg M, Otting G, and Mkrtchian S (2001). Thioredoxin fold as homodimerization module in the putative chaperone ERp29: NMR structures of the domains and experimental model of the 51 kDa dimer. Structure 9, 457–471. [DOI] [PubMed] [Google Scholar]
  46. Liu Y, Kahn RA, and Prestegard JH (2009). Structure and membrane interaction of myristoylated ARF1. Structure 17, 79–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Loh CT, Ozawa K, Tuck KL, Barlow N, Huber T, Otting G, and Graham B (2013). Lanthanide tags for site-specific ligation to an unnatural amino acid and generation of pseudocontact shifts in proteins. Bioconjug Chem 24, 260–268. [DOI] [PubMed] [Google Scholar]
  48. Loquet A, Sgourakis NG, Gupta R, Giller K, Riedel D, Goosmann C, Griesinger C, Kolbe M, Baker D, Becker S, et al. (2012). Atomic model of the type III secretion system needle. Nature 486, 276–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Meador WE, Means AR, and Quiocho FA (1992). Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science 257, 1251–1255. [DOI] [PubMed] [Google Scholar]
  50. Meiler J (2003). PROSHIFT: Protein Chemical Shift Prediction Using Artificial Neural Networks. J. Biomol. NMR 26, 25–37. [DOI] [PubMed] [Google Scholar]
  51. Meiler J, and Baker D (2003). Rapid protein fold determination using unassigned NMR data. Proc Natl Acad Sci U S A 100, 15404–15409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Meiler J, and Baker D (2006). ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. Proteins 65, 538–548. [DOI] [PubMed] [Google Scholar]
  53. Mueller GA, Kirby TW, DeRose EF, Li D, Schaaper RM, and London RE (2005). Nuclear magnetic resonance solution structure of the Escherichia coli DNA polymerase III theta subunit. J Bacteriol 187, 7081–7089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Noble CG, Seh CC, Chao AT, and Shi PY (2012). Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol 86, 438–446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ogura K, Shiga T, Yokochi M, Yuzawa S, Burke TR Jr., and Inagaki F (2008). Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor. J Biomol NMR 42, 197–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ovchinnikov S, Park H, Varghese N, Huang PS, Pavlopoulos GA, Kim DE, Kamisetty H, Kyrpides NC, and Baker D (2017). Protein structure determination using metagenome sequence data. Science 355, 294–298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Paramasivam S, Suiter CL, Hou G, Sun S, Palmer M, Hoch JC, Rovnyak D, and Polenova T (2012). Enhanced sensitivity by nonuniform sampling enables multidimensional MAS NMR spectroscopy of protein assemblies. J Phys Chem B 116, 7416–7427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Parge HE, Hallewell RA, and Tainer JA (1992). Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc Natl Acad Sci U S A 89, 6109–6113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Parsons LM, Grishaev A, and Bax A (2008). The periplasmic domain of TolR from Haemophilus influenzae forms a dimer with a large hydrophobic groove: NMR solution structure and comparison to SAXS data. Biochemistry 47, 3131–3142. [DOI] [PubMed] [Google Scholar]
  60. Pervushin K, Riek R, Wider G, and Wuethrich K (1997). Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. U. S. A. 94, 12366–12371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Pintacuda G, Park AY, Keniry MA, Dixon NE, and Otting G (2006). Lanthanide labeling offers fast NMR approach to 3D structure determinations of protein-protein complexes. J Am Chem Soc 128, 3696–3702. [DOI] [PubMed] [Google Scholar]
  62. Raman S, Lange OF, Rossi P, Tyka M, Wang X, Aramini J, Liu G, Ramelot TA, Eletsky A, Szyperski T, et al. (2010). NMR structure determination for larger proteins using backbone-only data. Science 327, 1014–1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Rathinavelan T, Lara-Tejero M, Lefebre M, Chatterjee S, McShan AC, Guo DC, Tang C, Galan JE, and De Guzman RN (2014). NMR model of PrgI-SipD interaction and its implications in the needle-tip assembly of the Salmonella type III secretion system. J Mol Biol 426, 2958–2969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Robinson PJ, Trnka MJ, Pellarin R, Greenberg CH, Bushnell DA, Davis R, Burlingame AL, Sali A, and Kornberg RD (2015). Molecular architecture of the yeast Mediator complex. Elife 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Rohl CA, and Baker D (2002). De novo determination of protein backbone structure from residual dipolar couplings using Rosetta. J Am Chem Soc 124, 2723–2729. [DOI] [PubMed] [Google Scholar]
  66. Rossi P, Shi L, Liu G, Barbieri CM, Lee HW, Grant TD, Luft JR, Xiao R, Acton TB, Snell EH, et al. (2015). A hybrid NMR/SAXS-based approach for discriminating oligomeric protein interfaces using Rosetta. Proteins 83, 309–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Russel D, Lasker K, Webb B, Velazquez-Muriel J, Tjioe E, Schneidman-Duhovny D, Peterson B, and Sali A (2012). Putting the pieces together: integrative structure determination of macromolecular assemblies. PLoS Biol 10, e1001244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Sachleben JR, McElroy CA, Gollnick P, and Foster MP (2010). Mechanism for pH-dependent gene regulation by amino-terminus-mediated homooligomerization of Bacillus subtilis anti-trp RNA-binding attenuation protein. Proc Natl Acad Sci U S A 107, 15385–15390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Saio T, Ogura K, Shimizu K, Yokochi M, Burke TR Jr., and Inagaki F (2011). An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe. J Biomol NMR 51, 395–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Saio T, Yokochi M, Kumeta H, and Inagaki F (2010). PCS-based structure determination of protein-protein complexes. J Biomol NMR 46, 271–280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Schmitz C, and Bonvin AM (2011). Protein-protein HADDocking using exclusively pseudocontact shifts. J Biomol NMR 50, 263–266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Schmitz C, Vernon R, Otting G, Baker D, and Huber T (2012). Protein structure determination from pseudocontact shifts using ROSETTA. J Mol Biol 416, 668–677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sgourakis NG, Lange OF, DiMaio F, Andre I, Fitzkee NC, Rossi P, Montelione GT, Bax A, and Baker D (2011). Determination of the structures of symmetric protein oligomers from NMR chemical shifts and residual dipolar couplings. J Am Chem Soc 133, 6288–6298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Shen Y, and Bax A (2015). Homology modeling of larger proteins guided by chemical shifts. Nat Methods 12, 747–750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Shen Y, Delaglio F, Cornilescu G, and Bax A (2009). TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR 44, 213–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Shen Y, Lange O, Delaglio F, Rossi P, Aramini JM, Liu GH, Eletsky A, Wu YB, Singarapu KK, Lemak A, et al. (2008). Consistent blind protein structure generation from NMR chemical shift data. Proceedings of the National Academy of Sciences of the United States of America 105, 4685–4690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Simons KT, Kooperberg C, Huang E, and Baker D (1997). Assembly of Protein Tertiary Structures from Fragments with Similar Local Sequences using Simulated Annealing and Bayesian Scoring Functions. J. Mol. Biol 268, 209–225. [DOI] [PubMed] [Google Scholar]
  78. Slupsky CM, Gentile LN, Donaldson LW, Mackereth CD, Seidel JJ, Graves BJ, and McIntosh LP (1998). Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc Natl Acad Sci U S A 95, 12129–12134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Strickland M, Stanley AM, Wang G, Botos I, Schwieters CD, Buchanan SK, Peterkofsky A, and Tjandra N (2016). Structure of the NPr:EIN(Ntr) Complex: Mechanism for Specificity in Paralogous Phosphotransferase Systems. Structure 24, 2127–2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Tang Y, Huang YJ, Hopf TA, Sander C, Marks DS, and Montelione GT (2015). Protein structure determination by combining sparse NMR data with evolutionary couplings. Nat Methods 12, 751–754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Teilum K, Hoch JC, Goffin V, Kinet S, Martial JA, and Kragelund BB (2005). Solution structure of human prolactin. J Mol Biol 351, 810–823. [DOI] [PubMed] [Google Scholar]
  82. Tugarinov V, and Kay LE (2005). Methyl groups as probes of structure and dynamics in NMR studies of high-molecular-weight proteins. Chembiochem 6, 1567–1577. [DOI] [PubMed] [Google Scholar]
  83. Tyka MD, Keedy DA, Andre I, Dimaio F, Song Y, Richardson DC, Richardson JS, and Baker D (2011). Alternate states of proteins revealed by detailed energy landscape mapping. J Mol Biol 405, 607–618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Ubbink M, Ejdeback M, Karlsson BG, and Bendall DS (1998). The structure of the complex of plastocyanin and cytochrome f, determined by paramagnetic NMR and restrained rigid-body molecular dynamics. Structure 6, 323–335. [DOI] [PubMed] [Google Scholar]
  85. Vakonakis I, Staunton D, Rooney LM, and Campbell ID (2007). Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis. EMBO J 26, 2575–2583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Vernon R, Shen Y, Baker D, and Lange OF (2013). Improved chemical shift based fragment selection for CS-Rosetta using Rosetta3 fragment picker. J Biomol NMR 57, 117–127. [DOI] [PubMed] [Google Scholar]
  87. Weiner BE, Alexander N, Akin LR, Woetzel N, Karakas M, and Meiler J (2014). BCL::Fold--protein topology determination from limited NMR restraints. Proteins 82, 587–595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Yagi H, Pilla KB, Maleckis A, Graham B, Huber T, and Otting G (2013). Three-dimensional protein fold determination from backbone amide pseudocontact shifts generated by lanthanide tags at multiple sites. Structure 21, 883–890. [DOI] [PubMed] [Google Scholar]
  89. Zheng D, Aramini JM, and Montelione GT (2004). Validation of helical tilt angles in the solution NMR structure of the Z domain of Staphylococcal protein A by combined analysis of residual dipolar coupling and NOE data. Protein Sci 13, 549–554. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data S1: Calculation details of the PCS, RDC, and PRE score; related to STAR Methods.

2

Data S2: Protocol development with RosettaNMR through the PyRosetta interface; related to STAR Methods.

3
4

Data S3: Protocol capture for RosettaNMR; related to STAR Methods.

Data Availability Statement

The Rosetta software is freely available for academic users at https://www.rosettacommons.org/. A license must be obtained from the University of Washington through the Express Licensing Program (https://www.rosettacommons.org/software/license-and-download). The paramagnetic RosettaNMR framework is part of Rosetta as of version v2019.02-dev60579 and later (for information see also: https://www.rosettacommons.org/docs/latest/application_documentation/RosettaNMR-with-Paramagnetic-Restraints). A protocol capture containing detailed instructions how to run RosettaNMR calculations with paramagnetic NMR data as well as accompanying input files and command lines is available with file Date S3. An example script for how to use RosettaNMR through PyRosetta is provided with file Data S2.

RESOURCES